94 related articles for article (PubMed ID: 9579692)
1. Neuronal protection of oligodendrocytes from antibody-independent complement lysis.
Agoropoulou C; Piddlesden SJ; Lachmann PJ; Wing MG
Neuroreport; 1998 Mar; 9(5):927-32. PubMed ID: 9579692
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59.
Wing MG; Zajicek J; Seilly DJ; Compston DA; Lachmann PJ
Immunology; 1992 May; 76(1):140-5. PubMed ID: 1378423
[TBL] [Abstract][Full Text] [Related]
3. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.
Piddlesden SJ; Morgan BP
J Neuroimmunol; 1993; 48(2):169-75. PubMed ID: 7693753
[TBL] [Abstract][Full Text] [Related]
4. Complement regulatory proteins and selective vulnerability of neurons to lysis on exposure to acetylcholinesterase antibody.
Tang H; Brimijoin S
J Neuroimmunol; 2001 Apr; 115(1-2):53-63. PubMed ID: 11282154
[TBL] [Abstract][Full Text] [Related]
5. Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system.
Zajicek J; Wing M; Skepper J; Compston A
Lab Invest; 1995 Jul; 73(1):128-38. PubMed ID: 7541492
[TBL] [Abstract][Full Text] [Related]
6. CD59 expression and complement susceptibility of human neuronal cell line (NTera2).
Agoropoulou C; Wing MG; Wood A
Neuroreport; 1996 Apr; 7(5):997-1004. PubMed ID: 8804039
[TBL] [Abstract][Full Text] [Related]
7. The expression of complement regulatory proteins by adult human oligodendrocytes.
Scolding NJ; Morgan BP; Compston DA
J Neuroimmunol; 1998 Apr; 84(1):69-75. PubMed ID: 9600710
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of oligodendrocyte interaction with normal human serum--defining the role of complement.
Zajicek J; Wing MG; Lachmann PJ; Compston DA
J Neurol Sci; 1992 Mar; 108(1):65-72. PubMed ID: 1624954
[TBL] [Abstract][Full Text] [Related]
10. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
[TBL] [Abstract][Full Text] [Related]
11. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
12. Oligodendroglial signal transduction systems are regulated by neuronal contact.
He M; Howe DG; McCarthy KD
J Neurochem; 1996 Oct; 67(4):1491-9. PubMed ID: 8858932
[TBL] [Abstract][Full Text] [Related]
13. The membrane attack complex of complement mediates peripheral nervous system demyelination in vitro.
Brück W; Brück Y; Diederich U; Piddlesden SJ
Acta Neuropathol; 1995; 90(6):601-7. PubMed ID: 8615080
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte-spinal cord explant co-culture: an in vitro model for the study of myelination.
Chen Z; Ma Z; Wang Y; Li Y; Lü H; Fu S; Hang Q; Lu PH
Brain Res; 2010 Jan; 1309():9-18. PubMed ID: 19879858
[TBL] [Abstract][Full Text] [Related]
15. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
Yuan FF; Bryant JA; Fletcher A
Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
[TBL] [Abstract][Full Text] [Related]
16. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord.
Keirstead HS; Blakemore WF
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1191-201. PubMed ID: 9370229
[TBL] [Abstract][Full Text] [Related]
17. Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.
Wren DR; Noble M
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):9025-9. PubMed ID: 2813437
[TBL] [Abstract][Full Text] [Related]
18. Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg").
Stangel M; Compston A; Scolding NJ
J Neuroimmunol; 2000 Mar; 103(2):195-201. PubMed ID: 10696915
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes.
Asakura K; Miller DJ; Murray K; Bansal R; Pfeiffer SE; Rodriguez M
J Neurosci Res; 1996 Feb; 43(3):273-281. PubMed ID: 8714516
[TBL] [Abstract][Full Text] [Related]
20. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
